NCT00871182View on ClinicalTrials.gov

Study to Evaluate the Safety and Efficacy of Inhaled PT001 in Patients With Chronic Obstructive Pulmonary Disease (COPD)

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

33

Participants

Timeline

Start Date

March 31, 2009

Primary Completion Date

September 30, 2009

Study Completion Date

September 30, 2009

Conditions
Chronic Obstructive Pulmonary Disease
Interventions
DRUG

Inhaled PT001

single dose, inhaled

DRUG

Inhaled Placebo

single dose, inhaled

DRUG

Tiotropium Handihaler

single dose, tiotropium 18 mcg administered via the Handihaler

Trial Locations (6)

29303

Spartanburg Medical Research, Spartanburg

33169

Elite Research Institute, Miami

45220

Cincinnati VAMC, Cincinnati

68198

Pulmonary and Critical Care Medicine, Omaha

80206

National Jewish Health, Denver

85381

Pivotal Research Centers, Peoria

Sponsors
All Listed Sponsors
lead

Pearl Therapeutics, Inc.

INDUSTRY